Orenitram (United Therapeutics Corp.)
Welcome to the PulseAid listing for the Orenitram drug offered from United Therapeutics Corp.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | United Therapeutics Corp. |
NON-PROPRIETARY NAME: | treprostinil |
SUBSTANCE NAME: | TREPROSTINIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-12-20 |
END MARKETING DATE: | 0000-00-00 |
Orenitram HUMAN PRESCRIPTION DRUG Details:
Item Description | Orenitram from United Therapeutics Corp. |
LABELER NAME: | United Therapeutics Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.125(mg/1) |
START MARKETING DATE: | 2013-12-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 66302-300_3d03a0e3-a4b7-4367-95c5-566ccf6f1da2 |
PRODUCT NDC: | 66302-300 |
APPLICATION NUMBER: | NDA203496 |
Other TREPROSTINIL Pharmaceutical Manufacturers / Labelers: